bioMerieux SA has acquired Hyglos GmbH to further develop its approaches in the detection of endotoxins within pharmaceutical products.

The sale consideration of the acquisition is $26.7m, which will be paid in phases over the next three years.

According to the agreement, Hyglos has been merged and consolidated into BioMerieux’s financial statements effective from 1 June 2016.

Recordati S.p.A plans to expand and strengthen its gastroenterology portfolio through its recent acquisition of 100% shares of Italchimici S.p.A.

The purchase consideration of the transaction is $145m, which has been funded from the existing facilities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.